Fifth Third Bancorp’s NeoGenomics NEO Stock Holding History

Fifth Third Bancorp’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$486K	Sell	33,291 -292	-0.9%	-$2.82K	﹤0.01%	2115
2026 Q1	$249K	Buy	33,583 +30,675	+1,055%	+$323K	﹤0.01%	2420
2025 Q4	$34.2K	Sell	2,908 -22	-0.8%	-$237	﹤0.01%	1643
2025 Q3	$22.6K	Buy	2,930 +101	+4%	+$707	﹤0.01%	1845
2025 Q2	$20.7K	Buy	2,829 +7	+0.2%	+$56	﹤0.01%	1767
2025 Q1	$26.8K	Sell	2,822 -51	-2%	-$637	﹤0.01%	1658
2024 Q4	$47.3K	Sell	2,873 -441	-13%	-$6.85K	﹤0.01%	1412
2024 Q3	$48.9K	Buy	3,314 +169	+5%	+$2.64K	﹤0.01%	1437
2024 Q2	$43.6K	Sell	3,145 -46	-1%	-$652	﹤0.01%	1421
2024 Q1	$50.2K	Sell	3,191 -48	-1%	-$741	﹤0.01%	1341
2023 Q4	$52.4K	Sell	3,239 -267	-8%	-$4.37K	﹤0.01%	1367
2023 Q3	$43.1K	Sell	3,506 -190	-5%	-$2.83K	﹤0.01%	1413
2023 Q2	$59.4K	Buy	3,696 +236	+7%	+$3.89K	﹤0.01%	1301
2023 Q1	$60.2K	Sell	3,460 -153	-4%	-$2.18K	﹤0.01%	1373
2022 Q4	$33.4K	Buy	3,613 +237	+7%	+$2.21K	﹤0.01%	1499
2022 Q3	$29K	Sell	3,376 -3,570	-51%	-$35.5K	﹤0.01%	1544
2022 Q2	$57K	Buy	6,946 +159	+2%	+$1.52K	﹤0.01%	1313
2022 Q1	$82K	Sell	6,787 -17,067	-72%	-$359K	﹤0.01%	1263
2021 Q4	$814K	Buy	23,854 +2,146	+10%	+$84K	﹤0.01%	606
2021 Q3	$1.05M	Buy	21,708 +410	+2%	+$19K	﹤0.01%	568
2021 Q2	$962K	Buy	21,298 +562	+3%	+$24.9K	﹤0.01%	583
2021 Q1	$1M	Buy	20,736 +589	+3%	+$30.7K	﹤0.01%	565
2020 Q4	$1.08M	Buy	20,147 +3,686	+22%	+$167K	0.01%	530
2020 Q3	$607K	Buy	16,461 +1,318	+9%	+$49K	﹤0.01%	607
2020 Q2	$469K	Buy	15,143 +1,016	+7%	+$28.2K	﹤0.01%	638
2020 Q1	$390K	Buy	14,127 +683	+5%	+$20.5K	﹤0.01%	652
2019 Q4	$393K	Buy	13,444 +723	+6%	+$17.2K	﹤0.01%	711
2019 Q3	$243K	Buy	12,721 +553	+5%	+$13K	﹤0.01%	858
2019 Q2	$267K	Buy	12,168 +668	+6%	+$14.7K	﹤0.01%	819
2019 Q1	$235K	Buy	11,500 +2,682	+30%	+$46.6K	﹤0.01%	837
2018 Q4	$111K	Hold	8,818	–	–	﹤0.01%	1011
2018 Q3	$135K	Buy	8,818 +2,749	+45%	+$38K	﹤0.01%	1010
2018 Q2	$80K	Hold	6,069	–	–	﹤0.01%	1174
2018 Q1	$50K	Buy	6,069 +1,759	+41%	+$14.3K	﹤0.01%	1329
2017 Q4	$38K	Buy	4,310 +310	+8%	+$2.86K	﹤0.01%	1364
2017 Q3	$45K	Hold	4,000	–	–	﹤0.01%	1322
2017 Q2	$36K	Hold	4,000	–	–	﹤0.01%	1388
2017 Q1	$32K	Hold	4,000	–	–	﹤0.01%	1439
2016 Q4	$34K	Hold	4,000	–	–	﹤0.01%	1463
2016 Q3	$33K	Hold	4,000	–	–	﹤0.01%	1456
2016 Q2	$32K	Hold	4,000	–	–	﹤0.01%	1429
2016 Q1	$27K	Hold	4,000	–	–	﹤0.01%	1536
2015 Q4	$31K	Hold	4,000	–	–	﹤0.01%	1539
2015 Q3	$23K	Hold	4,000	–	–	﹤0.01%	1684
2015 Q2	$22K	Hold	4,000	–	–	﹤0.01%	1767
2015 Q1	$19K	Hold	4,000	–	–	﹤0.01%	1773
2014 Q4	$17K	Hold	4,000	–	–	﹤0.01%	1769
2014 Q3	$21K	Hold	4,000	–	–	﹤0.01%	1748
2014 Q2	$13K	Hold	4,000	–	–	﹤0.01%	1930
2014 Q1	$14K	Hold	4,000	–	–	﹤0.01%	1896
2013 Q4	$14K	Hold	4,000	–	–	﹤0.01%	1764
2013 Q3	$12K	Hold	4,000	–	–	﹤0.01%	1826
2013 Q2	$16K	Buy	+4,000	New	+$15.3K	﹤0.01%	1660

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return

Fifth Third Bancorp's NEO Position: Q2 2026 in Review

Fifth Third Bancorp reduced its NeoGenomics (NEO) stake by 0.87% in Q2 2026, selling an estimated $2.82K and leaving 33,291 shares worth $486K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Fifth Third Bancorp first reported a position in NEO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.08M in Q4 2020. 95 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Fifth Third Bancorp held 33,291 shares of NeoGenomics worth $486K as of Q2 2026.
Fifth Third Bancorp sold 292 NeoGenomics shares in Q2 2026, an estimated $2.82K.
NeoGenomics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2115 holding.
Fifth Third Bancorp first reported a position in NeoGenomics in Q2 2013 and has held it in 53 quarters since.
Fifth Third Bancorp's NeoGenomics position peaked at $1.08M in Q4 2020.
95 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.